United Kingdom Amniocentesis Needle Market Size, Share, and COVID-19 Impact Analysis, By Product Type (100 to 150 mm, Smaller Than 100 mm, and Larger Than 150 mm), By Application (Amniocentesis Procedures, Fetal Blood Transfusion, Cordocentesis Procedure, Amnioreduction Procedures, and Amnioinfusion Procedure), and United Kingdom Amniocentesis Needle Market Insights, Industry Trend, Forecasts to 2035

United Kingdom Amniocentesis Needle Market Insights Forecasts to 2035

• The United Kingdom Amniocentesis Needle Market Size was Estimated at USD 10.90 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 6.04% from 2025 to 2035
• The United Kingdom Amniocentesis Needle Market Size is Expected to Reach USD 20.77 Million by 2035

According to a Research Report Published by Spherical Insights & Consulting, the United Kingdom Amniocentesis Needle Market Size is Anticipated to Reach USD 20.77 Million by 2035, Growing at a CAGR of 6.04% from 2025 to 2035. Growth in the market is ascribed to both the rise in high-risk pregnancies and the development of prenatal genetic testing technology. The need for these diagnostic instruments is anticipated to increase along with the rising prevalence of chronic illnesses that make pregnancy more difficult. Furthermore, a major driver propelling the market is the growing popularity of prenatal testing.

Market Overview

The United Kingdom amniocentesis needle market refers to the industry focused on the production and application of which involves removing amniotic fluid for analysis from a pregnant woman's uterus, which is essential for identifying fetal infections, genetic diseases, and the health of the unborn child. The precision, safety, and comfort of the treatment are being improved by advancements in needle design and technique, which is driving market expansion. The growing need for accurate prenatal genetic testing is driving a substantial expansion in the amniocentesis needle market. The increasing prevalence of high-risk pregnancies, particularly among women aged 35 and above, necessitates the timely and precise identification of chromosomal abnormalities. This greatly increases the need for sophisticated prenatal screening methods, of which amniocentesis needles are an essential component. This makes amniocentesis even more necessary to support accurate diagnoses. The operation is becoming more accurate, safe, and comfortable due to advancements in needle design and technique, which is driving market expansion.

Report Coverage

This research report categorizes the market for the United Kingdom amniocentesis needle market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the United Kingdom amniocentesis needle market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the United Kingdom amniocentesis needle market.

Driving Factors

The market for United Kingdom amniocentesis needle is boosted by technical developments in healthcare, particularly with advancements in diagnostic techniques and amniocentesis needle design. Furthermore, the market is driven by increasing healthcare spending and a growing demand for advanced prenatal diagnostics. Additionally, the demand for amniocentesis in this area is expected to increase due to the rising number of difficult pregnancies, particularly among older women. Additional funding supports research and development, which results in advancements in amniocentesis needles. The increased availability of prenatal diagnostics due to government measures to improve maternity care creates new opportunities for market expansion.

Restraining Factors

However, a major constraint in amniocentesis is the size and positioning of the needle, which needs to be carefully selected and manipulated to prevent harm to the fetus, placenta, or umbilical cord. There are restrictions on further limiting needle access, and raising the risk of problems includes variables including gestational age, uterine position, maternal obesity, and the presence of uterine fibroids.

Market Segmentation

The United Kingdom amniocentesis needle market share is classified into product type, and application.

• The 100 to 150 mm segment accounted for the largest share in 2024 and is projected to grow at a substantial CAGR over the forecast period.

The United Kingdom amniocentesis needle market is divided by product type into 100 to 150 mm, smaller than 100 mm, and larger than 150 mm. Among these, the 100 to 150 mm segment accounted for the largest share in 2024 and is projected to grow at a substantial CAGR during the forecast period. The widespread usage of because, in most situations, it can offer the ideal depth needed for precise sample collection. This assortment of needles ensures a high level of safety and effectiveness during amniocentesis, making them perfect for performing the procedure on patients with varying body types.

• The amniocentesis procedures segment held a significant share in 2024 and is expected to grow at a rapid pace during the forecast period.

The United Kingdom amniocentesis needle market is segmented by application into amniocentesis procedures, fetal blood transfusion, cordocentesis procedure, amnioreduction procedures, and amnioinfusion procedure. Among these, the amniocentesis procedures segment held a significant share in 2024 and is expected to grow at a rapid pace during the forecast period. This is because of the growing number of prenatal diagnostic procedures. As the necessity of screening for chromosomal abnormalities and genetic illnesses like Down syndrome increases, there will probably be a greater need for amniocentesis procedures.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the United Kingdom amniocentesis needle market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Rocket Medical
• Vygon
• Eurosurgical Ltd
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at United Kingdom, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the United Kingdom amniocentesis needle market based on the below-mentioned segments:

United Kingdom Amniocentesis Needle Market, By Product Type

• 100 to 150 mm
• Smaller Than 100 mm
• Larger Than 150 mm

United Kingdom Amniocentesis Needle Market, By Application

• Amniocentesis Procedures
• Fetal Blood Transfusion
• Cordocentesis Procedure
• Amnioreduction Procedures
• Amnioinfusion Procedure